Ionis Pharmaceuticals has concluded enrolment in the pivotal cohort (Cohort 1) of its Phase III REVEAL study of obudanersen ...

Ionis Pharmaceuticals IONS announced that it has completed enrollment in cohort 1 of the phase III REVEAL study, which is ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it has completed enrollment in the pivotal cohort (Cohort 1) ...

Add Yahoo as a preferred source to see more of our stories on Google. Actor Colin Farrell recently disclosed that his son, James, has Angelman syndrome, one of the driving factors behind Farrell's ...

A new review sheds light on the complex molecular mechanisms behind Angelman syndrome (AS), a rare neurogenetic disorder, and explores how cutting-edge gene-targeting therapies may offer more ...

Angelman syndrome affects roughly 1 in every 20,000 children and it has no approved treatment. Researchers recently published results of early tests of a gene therapy strategy for Angelman syndrome, a ...

Angelman syndrome is a rare neurodevelopmental disorder characterized by changes in brain structure, severe intellectual disability, impairments in speech, motor function, epilepsy, sleep, and unique ...

Actor Colin Farrell is launching a new foundation to raise awareness of a rare genetic condition called Angelman syndrome, so that his son and others with the disorder will have more support and ...

Lee and Rachel were overjoyed when, after five boys, they finally welcomed a baby girl to the family ...

Actor Colin Farrell and his ex-partner Kim Bordenave have been quite open about the condition that has afflicted their son, James Farrell, who has been diagnosed with Angelman Syndrome. News emerged ...